Industry

Life Sciences and Health Care

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires a partner with a holistic, collaborative approach and a global perspective. It calls for a strategy informed by asking the right questions and rooted in identifying creative solutions to...

Hogan Lovells Publications

FDA proposes new regulations to govern De Novo requests – will the process live up to its promise? Medical Device Alert

Last week the Food and Drug Administration (FDA) issued a proposed set of new regulations to further define and update the De Novo review process. Although De Novo review has been available ...

Quick view Full view

Hogan Lovells Publications

Regulatory Insights for Life Sciences and Health Care Investments: Medical Device and Technology

Investing in the life sciences industry without an understanding of the key regulatory factors that could determine a product’s success or failure could cost you millions of dollars.

Quick view Full view

Hogan Lovells Publications

Welcome to the real world: FDA issues long-awaited framework for evaluating the potential use of real-world evidence to support regulatory decisions for drugs and biologics Pharmaceutical and Biotechnology Alert

On December 6, the Food and Drug Administration (FDA) published a framework for its Real-World Evidence (RWE) Program to strategically leverage information gathered from real-world...

Quick view Full view

Published Works

Understanding the local cannabis industry – “weeding” out confusion Business Brief

Following the recent landmark decision of the South African Constitutional Court, in which the private and personal use of cannabis was decriminalised, together with the publication of...

Quick view Full view

Blog Post

China takes significant steps to consolidate generic drug industry and lower prices

On 7 December, China announced its newly implemented pilot centralized drug procurement program will cut prices for certain off-patent generic drugs by up to 96%. Under the program, China...

Quick view Full view

Boston Compliance Forum

Join the Hogan Lovells Boston team along with regional and international colleagues for an informative breakfast forum in Cambridge, MA. The forum features two sessions that explore a range ...

Quick view Full view
Loading data